nafamostat has been researched along with Colorectal Cancer in 1 studies
nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nafamostat mesilate is an anti-inflammatory drug that is usually used to treat pancreatitis." | 5.43 | Inhibition of the NF-κB pathway by nafamostat mesilate suppresses colorectal cancer growth and metastasis. ( Chen, G; Chen, LZ; Ju, HQ; Kang, TB; Lu, YX; Mo, HY; Pan, ZZ; Sheng, H; Wang, F; Wu, QN; Xie, D; Xu, RH; Yun, JP; Zeng, ZL, 2016) |
| "Nafamostat mesilate is an anti-inflammatory drug that is usually used to treat pancreatitis." | 1.43 | Inhibition of the NF-κB pathway by nafamostat mesilate suppresses colorectal cancer growth and metastasis. ( Chen, G; Chen, LZ; Ju, HQ; Kang, TB; Lu, YX; Mo, HY; Pan, ZZ; Sheng, H; Wang, F; Wu, QN; Xie, D; Xu, RH; Yun, JP; Zeng, ZL, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lu, YX | 1 |
| Ju, HQ | 1 |
| Wang, F | 1 |
| Chen, LZ | 1 |
| Wu, QN | 1 |
| Sheng, H | 1 |
| Mo, HY | 1 |
| Pan, ZZ | 1 |
| Xie, D | 1 |
| Kang, TB | 1 |
| Chen, G | 1 |
| Yun, JP | 1 |
| Zeng, ZL | 1 |
| Xu, RH | 1 |
1 other study available for nafamostat and Colorectal Cancer
| Article | Year |
|---|---|
Inhibition of the NF-κB pathway by nafamostat mesilate suppresses colorectal cancer growth and metastasis.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamidines; Cell Movement; Cel | 2016 |